HIGH_FIVE_HEALTH_PROMOTIO - Accounts


Company Registration No. 04349836 (England and Wales)
HIGH FIVE HEALTH PROMOTION LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
PAGES FOR FILING WITH REGISTRAR
HIGH FIVE HEALTH PROMOTION LIMITED
COMPANY INFORMATION
Directors
N F Gillespie
E Boer
(Appointed 27 June 2019)
J S Hogan
(Appointed 3 January 2020)
P Devine
(Appointed 3 January 2020)
D A Capper
(Appointed 3 January 2020)
Company number
04349836
Registered office
Westfield House
60 Charter Row
Sheffield
S1 3FZ
Accountants
Harwood Hutton Limited
22 Wycombe End
Beaconsfield
Buckinghamshire
HP9 1NB
HIGH FIVE HEALTH PROMOTION LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 8
HIGH FIVE HEALTH PROMOTION LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2019
31 December 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Tangible assets
3
38,109
107,874
Current assets
Debtors
4
402,578
352,038
Cash at bank and in hand
6,475
179,188
409,053
531,226
Creditors: amounts falling due within one year
5
(372,173)
(447,039)
Net current assets
36,880
84,187
Total assets less current liabilities
74,989
192,061
Creditors: amounts falling due after more than one year
6
-
(28,242)
Net assets
74,989
163,819
Capital and reserves
Called up share capital
7
511,053
511,053
Profit and loss reserves
(436,064)
(347,234)
Total equity
74,989
163,819

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

HIGH FIVE HEALTH PROMOTION LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2019
31 December 2019
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 23 March 2020 and are signed on its behalf by:
N F Gillespie
Director
Company Registration No. 04349836
HIGH FIVE HEALTH PROMOTION LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2019
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2018
111,053
(394,719)
(283,666)
Year ended 31 December 2018:
Profit and total comprehensive income for the year
-
47,485
47,485
Issue of share capital
7
400,000
-
400,000
Balance at 31 December 2018
511,053
(347,234)
163,819
Year ended 31 December 2019:
Loss and total comprehensive income for the year
-
(88,830)
(88,830)
Balance at 31 December 2019
511,053
(436,064)
74,989
HIGH FIVE HEALTH PROMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
- 4 -
1
Accounting policies
Company information

High Five Health Promotion Limited is a private company limited by shares incorporated in England and Wales. The principle place of business is at 2nd Floor, Titan Court, 3 Bishops Square, Hatfield, AL10 9NA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are presented in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable for the sale of goods and the rendering of services in the normal course of business, and is shown net of discounts and VAT.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
20% per annum on the straight line method
Fixtures, fittings & equipment
25% per annum on the straight line method
Computer equipment
25% per annum on the straight line method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ”Basic Financial Instruments” to all of its financial instruments.

 

Financial instruments are recognised in the company’s balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Short term debtors are measured at transaction price less any provision for impairment. Loans receivable are measured initially at fair value, net of transaction costs and are subsequently carried at amortised costs using the effective interest method, less any provision for impairment.

HIGH FIVE HEALTH PROMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Short term creditors are measured at transaction price. Other financial liabilities, including bank loans and other loans, are measured initially at fair value, net of transaction costs and are subsequently carried at amortised costs using the effective interest method.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.

 

A deferred tax asset is regarded as recoverable and therefore recognised only when, on the basis of all available evidence, it can be regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.8
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to the profit and loss account so as to produce a constant periodic rate of interest on the remaining balance of the liability.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in the profit and loss account for the period.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 35 (2018 - 37).

HIGH FIVE HEALTH PROMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 6 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2019
428,478
Additions
4,140
At 31 December 2019
432,618
Depreciation and impairment
At 1 January 2019
320,604
Depreciation charged in the year
73,905
At 31 December 2019
394,509
Carrying amount
At 31 December 2019
38,109
At 31 December 2018
107,874
4
Debtors
2019
2018
Amounts falling due within one year:
£
£
Trade debtors
278,428
217,495
Other debtors
21,335
52,104
299,763
269,599
Deferred tax asset
102,815
82,439
402,578
352,038
HIGH FIVE HEALTH PROMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 7 -
5
Creditors: amounts falling due within one year
2019
2018
£
£
Bank loans and overdrafts
3,832
-
Trade creditors
139,637
205,946
Amounts owed to group undertakings
84,511
15,635
Taxation and social security
75,871
73,226
Other creditors
68,322
152,232
372,173
447,039

Other creditors include £28,243 (2018: £81,261) of net obligations under hire purchase contracts, which are secured on the assets concerned.

6
Creditors: amounts falling due after more than one year
2019
2018
£
£
Other creditors
-
28,242

Other creditors include £nil (2018: £28,242) of net obligations under hire purchase contracts, which are secured on the assets concerned.

7
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
16,106 A Ordinary shares of £1 each
16,106
16,106
4,947 B Ordinary shares of £1 each
4,947
4,947
21,053
21,053
Preference share capital
Issued and fully paid
490,000 Preference shares of £1 each
490,000
490,000
Preference shares classified as equity
490,000
490,000
Total equity share capital
511,053
511,053
HIGH FIVE HEALTH PROMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 8 -
9
Parent company

The ultimate parent company is Kienstra Sport B.V., a company registered in The Netherlands.

 

Kientra Sport B.V. prepares group financial statements and copies can be obtained from Schinkeldijkje 18, 1432CE Aalsmeer, Postbus 9097, 1180MB, Amstelveen, The Netherlands.

2019-12-312019-01-01false24 March 2020CCH SoftwareCCH Accounts Production 2019.301No description of principal activityN F GillespieP G A KienstraE BoerE BoerJ S HoganP Devine043498362019-01-012019-12-3104349836bus:Director12019-01-012019-12-3104349836bus:Director42019-01-012019-12-3104349836bus:Director52019-01-012019-12-3104349836bus:Director62019-01-012019-12-3104349836bus:Director72019-01-012019-12-3104349836bus:Director22019-01-012019-12-3104349836bus:Director32019-01-012019-12-3104349836bus:RegisteredOffice2019-01-012019-12-31043498362019-12-31043498362018-12-3104349836core:OtherPropertyPlantEquipment2019-12-3104349836core:OtherPropertyPlantEquipment2018-12-3104349836core:CurrentFinancialInstrumentscore:WithinOneYear2019-12-3104349836core:CurrentFinancialInstrumentscore:WithinOneYear2018-12-3104349836core:CurrentFinancialInstruments2019-12-3104349836core:CurrentFinancialInstruments2018-12-3104349836core:Non-currentFinancialInstruments2018-12-3104349836core:ShareCapital2019-12-3104349836core:ShareCapital2018-12-3104349836core:RetainedEarningsAccumulatedLosses2019-12-3104349836core:RetainedEarningsAccumulatedLosses2018-12-3104349836core:ShareCapital2017-12-3104349836core:RetainedEarningsAccumulatedLosses2017-12-31043498362017-12-3104349836core:ShareCapitalOrdinaryShares2019-12-3104349836core:ShareCapitalOrdinaryShares2018-12-3104349836core:RetainedEarningsAccumulatedLosses2018-01-012018-12-31043498362018-01-012018-12-3104349836core:RetainedEarningsAccumulatedLosses2019-01-012019-12-3104349836core:ShareCapital2018-01-012018-12-3104349836core:PlantMachinery2019-01-012019-12-3104349836core:FurnitureFittings2019-01-012019-12-3104349836core:ComputerEquipment2019-01-012019-12-3104349836core:OtherPropertyPlantEquipment2018-12-3104349836core:OtherPropertyPlantEquipment2019-01-012019-12-3104349836core:WithinOneYear2019-12-3104349836core:WithinOneYear2018-12-3104349836bus:PrivateLimitedCompanyLtd2019-01-012019-12-3104349836bus:SmallCompaniesRegimeForAccounts2019-01-012019-12-3104349836bus:FRS1022019-01-012019-12-3104349836bus:AuditExemptWithAccountantsReport2019-01-012019-12-3104349836bus:FullAccounts2019-01-012019-12-31xbrli:purexbrli:sharesiso4217:GBP